We've found
27,461
archived clinical trials in
Hematology
We've found
27,461
archived clinical trials in
Hematology
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
Updated: 12/31/1969
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study. A Companion Observational Study to Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease
Updated: 12/31/1969
An Open-label, Multicenter, Multinational Extension Study of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Adult Male Patients Diagnosed With Fabry Disease
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease
Updated: 12/31/1969
An Open-label, Multicenter, Multinational Extension Study of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Adult Male Patients Diagnosed With Fabry Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease
Updated: 12/31/1969
An Open-label, Multicenter, Multinational Extension Study of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Adult Male Patients Diagnosed With Fabry Disease
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease
Updated: 12/31/1969
An Open-label, Multicenter, Multinational Extension Study of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Adult Male Patients Diagnosed With Fabry Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease
Updated: 12/31/1969
An Open-label, Multicenter, Multinational Extension Study of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Adult Male Patients Diagnosed With Fabry Disease
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease
Updated: 12/31/1969
An Open-label, Multicenter, Multinational Extension Study of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Adult Male Patients Diagnosed With Fabry Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease
Updated: 12/31/1969
An Open-label, Multicenter, Multinational Extension Study of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Adult Male Patients Diagnosed With Fabry Disease
Status: Enrolling
Updated: 12/31/1969
Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease
Updated: 12/31/1969
An Open-label, Multicenter, Multinational Extension Study of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Adult Male Patients Diagnosed With Fabry Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers
Updated: 12/31/1969
Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers
Status: Enrolling
Updated: 12/31/1969
Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers
Updated: 12/31/1969
Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers
Updated: 12/31/1969
Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers
Status: Enrolling
Updated: 12/31/1969
Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers
Updated: 12/31/1969
Characterization of Laboratory Response to DDAVP in Adult Hemophilia A Carriers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial
Updated: 12/31/1969
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept 2 Trial
Status: Enrolling
Updated: 12/31/1969
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial
Updated: 12/31/1969
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept 2 Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial
Updated: 12/31/1969
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept 2 Trial
Status: Enrolling
Updated: 12/31/1969
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial
Updated: 12/31/1969
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept 2 Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial
Updated: 12/31/1969
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept 2 Trial
Status: Enrolling
Updated: 12/31/1969
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial
Updated: 12/31/1969
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept 2 Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial
Updated: 12/31/1969
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept 2 Trial
Status: Enrolling
Updated: 12/31/1969
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial
Updated: 12/31/1969
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept 2 Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial
Updated: 12/31/1969
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept 2 Trial
Status: Enrolling
Updated: 12/31/1969
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial
Updated: 12/31/1969
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept 2 Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial
Updated: 12/31/1969
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept 2 Trial
Status: Enrolling
Updated: 12/31/1969
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept™2 Trial
Updated: 12/31/1969
Pharmacogenetic Testing of Saliva Samples From Patients With Five or More Exposure Days to rFVIIa Analogue in the Adept 2 Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis
Updated: 12/31/1969
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis Who Have Persistent Cardiac Dysfunction
Status: Enrolling
Updated: 12/31/1969
The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis
Updated: 12/31/1969
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis Who Have Persistent Cardiac Dysfunction
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis
Updated: 12/31/1969
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis Who Have Persistent Cardiac Dysfunction
Status: Enrolling
Updated: 12/31/1969
The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis
Updated: 12/31/1969
A Phase 2b, Randomized, Double-blind, Placebo-controlled Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis Who Have Persistent Cardiac Dysfunction
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
